Data Biologics, Llc announced it raised $95,000 in an amended filing from an offering of $2 Million

Company

Location

About

DataBiologics is solving a major problem with the lack of evidence and transparency for safety and efficacy in the emerging field of Regenerative Medicine. Today, these therapies are primarily cash-pay and use the patient’s own tissue healing response or cells as the source of treatment, such as those found in blood, fat, and bone marrow. Our software enables physicians with a simple, yet highly-tailored data capture solution to personalize the treatment decisions and experience for patients, and also ethically drive adoption of new techniques by physicians. Our proprietary database, generated exclusively by our software application, combined with machine learning algorithms, is delivering never-before accessed insights to advance patient access to emerging treatments.